Immunity to mumps before and after MMR vaccination at 12 years of age in the first generation offered the two-dose immunization programme

This publication has 18 references indexed in Scilit:

• Immunity to rubella before and after vaccination against measles, mumps and rubella (MMR) at 12 years of age of the first generation offered MMR vaccination in Sweden at 18 months
  Vaccine, 1995
• Antibodies to measles, mumps and rubella in UK children 4 years after vaccination with different MMR vaccines
  Vaccine, 1995
• Measles, mumps, and rubella antibodies in children 5–6 years after immunization: effect of vaccine type and age at vaccination
  Vaccine, 1995
• The Elimination of Indigenous Measles, Mumps, and Rubella from Finland by a 12-Year, Two-Dose Vaccination Program
  New England Journal of Medicine, 1994
• Changes of the immunological patterns against measles, mumps and rubella. A vaccination programme studied 3 to 7 years after the introduction of a two-dose schedule
  Vaccine, 1991
• Swedish experience of two dose vaccination programme aiming at eliminating measles, mumps, and rubella.
  BMJ, 1987
• Vaccination against measles, mumps and rubella (MMR): A comparison between the antibody responses at the ages of 18 months and 12 years and between different methods of antibody titration
  Journal of Biological Standardization, 1985
• Scandinavian model for eliminating measles, mumps, and rubella.
  BMJ, 1984
• Mass vaccination programme aimed at eradicating measles, mumps, and rubella in Sweden: first experience.
  BMJ, 1983
• Conversion rates and side effects following vaccination with three different batches of the ‘Schwarz’ measles strain
  Journal of Biological Standardization, 1973